These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 31389577

  • 1. MiRNA-27a-3p promotes osteogenic differentiation of human mesenchymal stem cells through targeting ATF3.
    Fu YC, Zhao SR, Zhu BH, Guo SS, Wang XX.
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):73-80. PubMed ID: 31389577
    [Abstract] [Full Text] [Related]

  • 2. MiRNA-19a-3p alleviates the progression of osteoporosis by targeting HDAC4 to promote the osteogenic differentiation of hMSCs.
    Chen R, Qiu H, Tong Y, Liao F, Hu X, Qiu Y, Liao Y.
    Biochem Biophys Res Commun; 2019 Aug 27; 516(3):666-672. PubMed ID: 31248594
    [Abstract] [Full Text] [Related]

  • 3. MicroRNA-579-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of mesenchymal stem cells through regulating Sirt1.
    Luo B, Yang JF, Wang YH, Qu GB, Hao PD, Zeng ZJ, Yuan J, Yang R, Yuan Y.
    Eur Rev Med Pharmacol Sci; 2019 Aug 27; 23(16):6791-6799. PubMed ID: 31486477
    [Abstract] [Full Text] [Related]

  • 4. MiRNA-365a-3p promotes the progression of osteoporosis by inhibiting osteogenic differentiation via targeting RUNX2.
    Cheng F, Yang MM, Yang RH.
    Eur Rev Med Pharmacol Sci; 2019 Sep 27; 23(18):7766-7774. PubMed ID: 31599402
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-200a-3p accelerates the progression of osteoporosis by targeting glutaminase to inhibit osteogenic differentiation of bone marrow mesenchymal stem cells.
    Lv R, Pan X, Song L, Sun Q, Guo C, Zou S, Zhou Q.
    Biomed Pharmacother; 2019 Aug 27; 116():108960. PubMed ID: 31112871
    [Abstract] [Full Text] [Related]

  • 6. Teriparatide alleviates osteoporosis by promoting osteogenic differentiation of hMSCs via miR-375/RUNX2 axis.
    Lei NB, Liang X, Wang P, Liu Q, Wang WG.
    Eur Rev Med Pharmacol Sci; 2019 Dec 27; 23(24):11043-11050. PubMed ID: 31858576
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-1286 inhibits osteogenic differentiation of mesenchymal stem cells to promote the progression of osteoporosis via regulating FZD4 expression.
    Zhou JG, Hua Y, Liu SW, Hu WQ, Qian R, Xiong L.
    Eur Rev Med Pharmacol Sci; 2020 Jan 27; 24(1):1-10. PubMed ID: 31957812
    [Abstract] [Full Text] [Related]

  • 8. LncRNA XIXT promotes osteogenic differentiation of bone mesenchymal stem cells and alleviates osteoporosis progression by targeting miRNA-30a-5p.
    Zhang HL, Du XY, Dong QR.
    Eur Rev Med Pharmacol Sci; 2019 Oct 27; 23(20):8721-8729. PubMed ID: 31696458
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of miR-339 promotes differentiation of BMSCs and alleviates osteoporosis by targeting DLX5.
    Zhou J, Nie H, Liu P, Wang Z, Yao B, Yang L.
    Eur Rev Med Pharmacol Sci; 2019 Jan 27; 23(1):29-36. PubMed ID: 30657543
    [Abstract] [Full Text] [Related]

  • 10. MiRNA-128-3p induces osteogenic differentiation of bone marrow mesenchymal stem cells via activating the Wnt3a signaling.
    Lin YP, Liao LM, Liu QH, Ni Y, Zhong Y, Yu S.
    Eur Rev Med Pharmacol Sci; 2021 Feb 27; 25(3):1225-1232. PubMed ID: 33629292
    [Abstract] [Full Text] [Related]

  • 11. MiR-27a is Essential for the Shift from Osteogenic Differentiation to Adipogenic Differentiation of Mesenchymal Stem Cells in Postmenopausal Osteoporosis.
    You L, Pan L, Chen L, Gu W, Chen J.
    Cell Physiol Biochem; 2016 Feb 27; 39(1):253-65. PubMed ID: 27337099
    [Abstract] [Full Text] [Related]

  • 12. MiR-27a-3p promotes the osteogenic differentiation by activating CRY2/ERK1/2 axis.
    Ren LR, Yao RB, Wang SY, Gong XD, Xu JT, Yang KS.
    Mol Med; 2021 Apr 26; 27(1):43. PubMed ID: 33902432
    [Abstract] [Full Text] [Related]

  • 13. Low-magnitude vibration induces osteogenic differentiation of bone marrow mesenchymal stem cells via miR-378a-3p/Grb2 pathway to promote bone formation in a rat model of age-related bone loss.
    Yu X, Zeng Y, Bao M, Wen J, Zhu G, Cao C, He X, Li L.
    FASEB J; 2020 Sep 26; 34(9):11754-11771. PubMed ID: 32652777
    [Abstract] [Full Text] [Related]

  • 14. microRNA-1297 promotes the progression of osteoporosis through regulation of osteogenesis of bone marrow mesenchymal stem cells by targeting WNT5A.
    Wang Q, Wang CH, Meng Y.
    Eur Rev Med Pharmacol Sci; 2019 Jun 26; 23(11):4541-4550. PubMed ID: 31210281
    [Abstract] [Full Text] [Related]

  • 15. MiRNA-7b-5p attenuates the progression of osteoporosis by inhibiting adipose differentiation of hMSCs via regulating IRS2.
    Li QQ, Wei Q, Zhai XC, Qin L, Li HB, Meng R, Chen SC.
    Eur Rev Med Pharmacol Sci; 2019 Nov 26; 23(21):9207-9214. PubMed ID: 31773671
    [Abstract] [Full Text] [Related]

  • 16. A novel miR-466l-3p/FGF23 axis promotes osteogenic differentiation of human bone marrow mesenchymal stem cells.
    Zhang X, Xu J.
    Bone; 2024 Aug 26; 185():117123. PubMed ID: 38735373
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of long non-coding RNA MEG3 suppresses osteogenic differentiation of periodontal ligament stem cells (PDLSCs) through miR-27a-3p/IGF1 axis in periodontitis.
    Liu Y, Liu C, Zhang A, Yin S, Wang T, Wang Y, Wang M, Liu Y, Ying Q, Sun J, Wei F, Liu D, Wang C, Ge S.
    Aging (Albany NY); 2019 Aug 09; 11(15):5334-5350. PubMed ID: 31398715
    [Abstract] [Full Text] [Related]

  • 18. LncRNA GAS5 overexpression alleviates the development of osteoporosis through promoting osteogenic differentiation of MSCs via targeting microRNA-498 to regulate RUNX2.
    Feng J, Wang JX, Li CH.
    Eur Rev Med Pharmacol Sci; 2019 Sep 09; 23(18):7757-7765. PubMed ID: 31599401
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-7-5p regulates osteogenic differentiation of hMSCs via targeting CMKLR1.
    Chen B, Meng J, Zeng YT, Du YX, Zhang J, Si YM, Yuan X.
    Eur Rev Med Pharmacol Sci; 2018 Nov 09; 22(22):7826-7831. PubMed ID: 30536327
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-449b-5p promotes the progression of osteoporosis by inhibiting osteogenic differentiation of BMSCs via targeting Satb2.
    Li JY, Wei X, Sun Q, Zhao XQ, Zheng CY, Bai CX, Du J, Zhang Z, Zhu LG, Jia YS.
    Eur Rev Med Pharmacol Sci; 2019 Aug 09; 23(15):6394-6403. PubMed ID: 31378877
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.